Search

Your search keyword '"Technetium Tc 99m Mertiatide pharmacokinetics"' showing total 30 results

Search Constraints

Start Over You searched for: Descriptor "Technetium Tc 99m Mertiatide pharmacokinetics" Remove constraint Descriptor: "Technetium Tc 99m Mertiatide pharmacokinetics" Topic radioisotope renography Remove constraint Topic: radioisotope renography
30 results on '"Technetium Tc 99m Mertiatide pharmacokinetics"'

Search Results

1. Nondiagnostic 99m Tc-MAG3 Diuresis Renography Studies Caused by Propofol Sedation : A Case Series.

2. Dosimetry of 99m Tc (DTPA, DMSA and MAG3) used in renal function studies of newborns and children.

3. Predictors of Renal Functional Improvement After Pyeloplasty in Ureteropelvic Junction Obstruction: Clinical Value of Visually Assessed Renal Tissue Tracer Transit in 99m Tc-mercaptoacetyltriglycine Renography.

4. Interobserver agreement on cortical tracer transit in 99mTc-MAG3 renography applied to congenital hydronephrosis.

5. Effect of sulfa drugs on kidney function and renal scintigraphy.

6. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.

7. Dynamic (99m)Tc-MAG3 renography: images for quality control obtained by combining pharmacokinetic modelling, an anthropomorphic computer phantom and Monte Carlo simulated scintillation camera imaging.

8. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling.

9. Pharmacokinetics of (99m)Tc-MAG3.

10. Optimal scintigraphic evaluation of a hydronephrotic horseshoe kidney.

11. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.

12. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography.

13. Recovery of renal retention function by differentiating the Patlak-Rutland plot.

14. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.

15. Administered activity optimization in 99mTc-MAG3 renography for adults.

16. Calculation of renal retention function without deconvolution.

17. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.

18. Factors affecting the hepatobiliary excretion of 99mTc-MAG3: its clinical significance in routine renography.

19. Unilateral vesicoureteral reflux detected by diuretic renography without voiding.

20. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.

21. Estimation of 99mTc-MAG3 clearance by single-sample methods and camera-based methods.

22. Aspirin renography and captopril renography in the diagnosis of renal artery stenosis.

23. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty.

24. Renography before heart transplantation in patients with cardiomyopathy.

25. [Nuclear nephrology].

26. Renogram deconvolution in the management of diabetic nephropathy: utility of the measurement of initial tracer uptake.

27. Steady-state captopril renography: continuous monitoring of the captopril-induced increase in 99mTc-MAG3 mean parenchymal transit time in renovascular hypertension.

28. Expressing kidney uptake during 99Tcm-MAG3 renography in terms of administered activity.

29. 99Tcm-MAG3 renogram deconvolution in normal subjects and in normal functioning kidney grafts.

30. What proportion of isotope injected does the child receive in dynamic renal scanning?

Catalog

Books, media, physical & digital resources